Global Liver Institute

Is Your Liver Healthy?

GLOBAL LIVER INSTITUTE

Is Your Liver Healthy?

At Global Liver Institute, we believe it all starts with a patient.

Did you know that an estimated 1.5 billion people around the world are affected by a liver condition?

This fact might lead you to the core question of this show: Is Your Liver Healthy? In monthly conversations, our host Jeff McIntyre explores a new part of the answer to this question by sitting down with the people who know the most about liver health and related conditions – whether that’s through their medical research, training and practice, personal experiences, or professional work. Join each month to learn what affects liver health, how liver disease impacts lives, and the actions we can all take to improve liver health for ourselves and our communities.

“Is Your Liver Healthy?” is produced by Global Liver Institute (GLI). It was born out of the interview show GLI LIVE, which GLI started in March 2020 as a COVID-19 response program for liver patients.

Check out the show on YouTube, Spotify, Apple Podcasts, Amazon Music, Audible, or wherever you get your podcasts!

See All Episodes of Is Your Liver Healthy? on

With the technical tools to eliminate viral hepatitis C available, focus must now be directed on garnering the political will to fund elimination efforts and deploying a harm reduction approach that can meaningfully impact affected populations by meeting them where they are and preventing damage to liver health and well-being before it happens.

In this month's episode of Is Your Liver Healthy?, guest host Gina Bartes, Vice President at Global Liver Institute, is joined by Dr. Beth Meyerson, director of the Harm Reduction Research Lab and Beverly Benson McCord Endowed Chair of Nursing at the University of Arizona, and Dr. Richard Manch, Chief of Hepatology at Arizona Liver Health.

To view your state's Report Card for Medicaid coverage of hepatitis C treatment, please visit https://stateofhepc.org/ (US residents).

#HepatitisAwarenessMonth

With the technical tools to eliminate viral hepatitis C available, focus must now be directed on garnering the political will to fund elimination efforts and deploying a harm reduction approach that can meaningfully impact affected populations by meeting them where they are and preventing damage to liver health and well-being before it happens.

In this month's episode of Is Your Liver Healthy?, guest host Gina Bartes, Vice President at Global Liver Institute, is joined by Dr. Beth Meyerson, director of the Harm Reduction Research Lab and Beverly Benson McCord Endowed Chair of Nursing at the University of Arizona, and Dr. Richard Manch, Chief of Hepatology at Arizona Liver Health.

To view your state's Report Card for Medicaid coverage of hepatitis C treatment, please visit https://stateofhepc.org/ (US residents).

#HepatitisAwarenessMonth

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy4xMkVGQjNCMUM1N0RFNEUx

Getting Out of Our Own Way: Hepatitis C Elimination

Why are organ donation and transplantation so important to people with liver disease? Hear from a pediatric transplant recipient and her transplant surgeon on the process, the challenges, and the importance of organ donation to community well-being!

This month's guests:
Sophie Hansen, 2x Liver Transplant Recipient
Dr. Manuel Rodriguez-Davalos, Transplant Hepatologist & President of the Society of Pediatric Liver Transplantation (SPLIT) https://tts.org/split-home

Why are organ donation and transplantation so important to people with liver disease? Hear from a pediatric transplant recipient and her transplant surgeon on the process, the challenges, and the importance of organ donation to community well-being!

This month's guests:
Sophie Hansen, 2x Liver Transplant Recipient
Dr. Manuel Rodriguez-Davalos, Transplant Hepatologist & President of the Society of Pediatric Liver Transplantation (SPLIT) https://tts.org/split-home

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy4wOTA3OTZBNzVEMTUzOTMy

The Power of Liver Transplantation

GLP-1s, or glucagon-like peptide-1 receptor agonists, are a class of medications used to treat type 2 diabetes, obesity, kidney disease, and other conditions. These drugs mimic GLP-1, a hormone that affects insulin release, slows stomach emptying, and affects satiety. Early studies suggest that GLP-1 drugs can benefit liver health as well. Explore the basics and what liver patients should know about GLP-1s with this month's guests:

Joe Naglowski, President & CEO, Obesity Action Coalition (https://www.obesityaction.org/)
Dr. Janese Laster, Gastroenterologist & founder of Gut Theory Total Digestive Care (https://www.guttheoryhealth.com/)

This video is private.

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy41MjE1MkI0OTQ2QzJGNzNG

GLP-1s & Your Liver (Is Your Liver Healthy? Episode 3)

Patients with rare (liver) diseases need access to clinical trials, but those in rural areas lack access due to structural and geographic barriers – which affects opportunities and generalizability of data for everyone.

This Rare Liver Diseases Month, GLI is focusing on the issues affecting Rare & Rural communities. In this episode, hear from our guests on the challenges for rare & rural liver disease patients in their communities.

Learn about our guests & their upcoming events:
Dr. Harsha Rajasimha - IndoUSRare (https://www.indousrare.org/)
Dr. Cecilia Dueñas - PBC Research Foundation (https://www.pbcresearchfoundation.org/)
Teresa Davidson - Mid South Liver Alliance (https://midsouthliveralliance.org/)
Kristin Hatcher - Global Liver Institute (https://globalliver.org/rare-liver-diseases-month/)

Learn more about Global Liver Institute on our website: https://globalliver.org.

Patients with rare (liver) diseases need access to clinical trials, but those in rural areas lack access due to structural and geographic barriers – which affects opportunities and generalizability of data for everyone.

This Rare Liver Diseases Month, GLI is focusing on the issues affecting Rare & Rural communities. In this episode, hear from our guests on the challenges for rare & rural liver disease patients in their communities.

Learn about our guests & their upcoming events:
Dr. Harsha Rajasimha - IndoUSRare (https://www.indousrare.org/)
Dr. Cecilia Dueñas - PBC Research Foundation (https://www.pbcresearchfoundation.org/)
Teresa Davidson - Mid South Liver Alliance (https://midsouthliveralliance.org/)
Kristin Hatcher - Global Liver Institute (https://globalliver.org/rare-liver-diseases-month/)

Learn more about Global Liver Institute on our website: https://globalliver.org.

YouTube Video UExqMWFXM3l6RnhLTzFEcmxPMDJMSHlpRUxfUWRQcjhLUy4wMTcyMDhGQUE4NTIzM0Y5

Rare & Rural Access to Care and Research (Is Your Liver Healthy? Episode 2)

Load More... Subscribe